Vaginal Contraceptive N-9 Label Warnings Urged “As Soon As Possible” – FDA

Manufacturers of vaginal contraceptives containing nonoxynol-9 should voluntarily implement proposed label warnings about increased vaginal irritation and HIV infection risk "as soon as possible," FDA advises in a 1Jan. 16 proposed rule